Nickas M E, Kessler R, Kabalin J N
Department of Urology, Stanford University Medical Center, California.
Urology. 1994 Sep;44(3):400-3. doi: 10.1016/s0090-4295(94)80101-0.
OBJECTIVEs. To determine complication and survival rates of the AMS 700CX penile prosthesis and to compare its reliability with earlier versions of the Scott inflatable penile prosthesis.
Retrospective chart review and telephone interviews were used.
Actual 4-year survival of the AMS 700CX device was 85%, whereas earlier versions of the device had actual 4-year survival of 46% (p < 0.0001). The observed difference in prosthesis reliability could not be accounted for by differences in patient population, surgical technique, or incidence of infections. The most significant factor that contributed to improved prosthesis survival was the lack of cylinder complications (leaks and aneurysms).
The controlled expansion cylinders of the AMS 700CX penile prosthesis are a significant advance in reliable, low-morbidity surgical therapy for impotence.
目的。确定AMS 700CX阴茎假体的并发症和生存率，并将其可靠性与早期版本的斯科特可膨胀阴茎假体进行比较。
采用回顾性病历审查和电话访谈。
AMS 700CX装置的实际4年生存率为85%，而该装置的早期版本实际4年生存率为46%（p<0.0001）。假体可靠性的观察差异不能用患者群体、手术技术或感染发生率的差异来解释。导致假体生存率提高的最重要因素是缺乏圆柱体并发症（渗漏和动脉瘤）。
AMS 700CX阴茎假体的可控膨胀圆柱体是阳痿可靠、低发病率手术治疗的一项重大进展。
